Literature DB >> 9152338

Reporting of adverse events in hospitals in Victoria, 1994-1995.

D A O'Hara1, N J Carson.   

Abstract

OBJECTIVE: To describe the nature and frequency of adverse events (AEs) reported in routine inpatient data collection.
DESIGN: Retrospective analysis of data from the Victorian Inpatient Minimum Database.
SETTING: All public (135) and private (112) acute-care hospitals in Victoria, 1994-1995. PARTICIPANTS: All patients with separations recording an E-code identified as an AE through the International classification of diseases, ninth revision (ICD-9), classification system. MAIN OUTCOME MEASURES: Australian national diagnosis-related groups (AN-DRGs) associated with AEs; prevalence of major organ system disease in each of the AE groups; AE rates by hospital type; and impact of AEs on discharge destination, or death.
RESULTS: AEs were recorded in 5% of separations, with incidence increasing with patient age. Most (81%) were complications after surgery or other procedures (E878-E879); 19% were adverse drug effects (E930-E949) and 1.7% were misadventures (E870-E876). The most frequently reported complications were infections, haemorrhage and pneumonia. AN-DRGs--joint replacement of the lower limb, bowel excision and hysterectomy--contributed most to the volume of AEs, while the greatest risk was associated with ventricular shunt, major organ transplantation and surgery for complicated injuries. The in-hospital death rate in patients with AEs was 2.9% (95% confidence interval [95% CI], 2.7%-3.2%), compared with 1.3% (95% CI, 1.0-1.4) in those without an AE. Of patients with an AE, fewer were discharged directly home, and higher proportions were discharged to other acute-care facilities or nursing homes compared with those without an AE.
CONCLUSION: Inpatient data collection can provide information about AE rates associated with individual procedures, and the nature of these AEs. It can be used by hospitals to direct and complement their own quality improvement activities. Its limitation is that it cannot identify the severity or long term outcome of AEs.

Entities:  

Mesh:

Year:  1997        PMID: 9152338     DOI: 10.5694/j.1326-5377.1997.tb123216.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

Review 1.  Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.

Authors:  Zeeshan Butt; Neehar D Parikh; Anton I Skaro; Daniela Ladner; David Cella
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

Review 2.  The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.

Authors:  L M Weekes; R O Day
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 3.  Impact of sample size on variation of adverse events and preventable adverse events: systematic review on epidemiology and contributing factors.

Authors:  Constanze Lessing; Astrid Schmitz; Bernhard Albers; Matthias Schrappe
Journal:  Qual Saf Health Care       Date:  2010-08-02

4.  Nursing home-sensitive conditions: analysis of routine health insurance data and modified Delphi analysis of potentially avoidable hospitalizations.

Authors:  Sabine Bohnet-Joschko; Maria Paula Valk-Draad; Timo Schulte; Oliver Groene
Journal:  F1000Res       Date:  2021-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.